Label: CALAMINE PLUS- calamine plus pramoxine hcl aerosol, spray
- NDC Code(s): 83324-242-41
- Packager: Chain Drug Marketing Association Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 11, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients
- Purpose
- Uses
-
Warnings
For external use only.
Flammable:
Do not use while smoking or near heat or flame. Do not puncture or incinerate. Contents under pressure. Do not store at temperatures above 120°F. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.
When using this product
- do not get into eyes
- ask a doctor before using on children under 2 years of age
- Directions
- Inactive ingredients
- Questions?
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
CALAMINE PLUS
calamine plus pramoxine hcl aerosol, sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:83324-242 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FERRIC OXIDE RED (UNII: 1K09F3G675) (FERRIC OXIDE RED - UNII:1K09F3G675) FERRIC OXIDE RED 5 mg in 1 g PRAMOXINE HYDROCHLORIDE (UNII: 88AYB867L5) (PRAMOXINE - UNII:068X84E056) PRAMOXINE HYDROCHLORIDE 10 mg in 1 g ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 79.5 mg in 1 g Inactive Ingredients Ingredient Name Strength CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET) ISOBUTANE (UNII: BXR49TP611) BENZYL ALCOHOL (UNII: LKG8494WBH) OLEYL ALCOHOL (UNII: 172F2WN8DV) SORBITAN TRIOLEATE (UNII: QE6F49RPJ1) ALCOHOL (UNII: 3K9958V90M) HYDRATED SILICA (UNII: Y6O7T4G8P9) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:83324-242-41 116 g in 1 CANISTER; Type 0: Not a Combination Product 06/07/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M017 06/07/2024 Labeler - Chain Drug Marketing Association Inc (011920774)